MERSANA THERAPEUTICS INC's ticker is MRSN and the CUSIP is 59045L106. A total of 136 filers reported holding MERSANA THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 0.11 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2020 | $2,395,000 | +42.9% | 90,000 | 0.0% | 0.02% | +18.8% |
Q3 2020 | $1,676,000 | -20.4% | 90,000 | 0.0% | 0.02% | -27.3% |
Q2 2020 | $2,106,000 | +222.5% | 90,000 | -78.2% | 0.02% | +214.3% |
Q3 2019 | $653,000 | -93.5% | 413,525 | -83.2% | 0.01% | -92.7% |
Q2 2019 | $9,981,000 | -41.0% | 2,464,415 | -23.4% | 0.10% | -39.6% |
Q1 2019 | $16,916,000 | +104.5% | 3,216,002 | +58.6% | 0.16% | +82.8% |
Q4 2018 | $8,272,000 | -55.1% | 2,027,505 | +10.2% | 0.09% | -43.5% |
Q3 2018 | $18,403,000 | -17.6% | 1,840,333 | +47.1% | 0.15% | -24.9% |
Q2 2018 | $22,342,000 | +51.9% | 1,250,977 | +34.2% | 0.20% | +39.5% |
Q1 2018 | $14,704,000 | -0.5% | 932,396 | +3.6% | 0.15% | -2.0% |
Q4 2017 | $14,783,000 | +79.0% | 899,773 | +88.4% | 0.15% | +59.6% |
Q3 2017 | $8,260,000 | +68.9% | 477,711 | +36.5% | 0.09% | +54.1% |
Q2 2017 | $4,890,000 | – | 350,000 | – | 0.06% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sarissa Capital Management LP | 4,005,600 | $54,396,000 | 4.32% |
Bain Capital Life Sciences Investors, LLC | 3,695,667 | $50,187,000 | 3.29% |
COMMODORE CAPITAL LP | 429,228 | $5,829,000 | 2.03% |
Ghost Tree Capital, LLC | 450,000 | $6,111,000 | 1.68% |
Avoro Capital Advisors LLC | 6,800,000 | $92,344,000 | 1.61% |
RHO CAPITAL PARTNERS INC | 796,458 | $10,816,000 | 0.99% |
Rock Springs Capital Management LP | 2,845,618 | $38,643,000 | 0.76% |
SILVERARC CAPITAL MANAGEMENT, LLC | 125,123 | $1,699,000 | 0.76% |
HighVista Strategies LLC | 59,906 | $814,000 | 0.58% |
Sio Capital Management, LLC | 157,259 | $2,136,000 | 0.53% |